Fri. 8 Mar 2024, 8:05am ET
Benzinga
Earnings, Earnings Misses, News
Ocuphire Pharma (NASDAQ:OCUP) reported quarterly losses of $(0.210) per share which missed the analyst consensus estimate of $(0.050) by 320 percent. The company reported quarterly sales of $1.700 million which missed the analyst consensus estimate of $5.349 million by 68.22 percent. This is a 95.73 percent decrease over sales of $39.850 million the same period last year.